Eroğlu Ayşe, Suzan Özge Karakaya, Kolukısa Tuğçe, Kaya Özge, Karaaslan Mehtap Metin, Çaycı Yeliz Tanrıverdi, Altındiş Mustafa, Bektaş Murat, Çınar Nursan
Department of Nursing, Institute of Health Sciences, Sakarya University, Esentepe Campus, Serdivan, Sakarya, 54187, Turkey.
Department of Nursing, School of Health Sciences, Sakarya University, Sakarya, Turkey.
Infection. 2025 Feb;53(1):427-436. doi: 10.1007/s15010-024-02395-7. Epub 2024 Sep 27.
This study aimed to present an evidence-based conclusion through a systematic meta-analysis to distinguish clinical signs and symptoms associated with the presence of group A beta-hemolytic streptococcus, as confirmed by throat culture or rapid test, from those in cases without culture confirmation.
The study protocol has been published in PROSPERO (CRD42023450854). Studies published between January 1, 2013 and August 15, 2023 were scanned in seven databases. The methodological quality of the articles was assessed using The Joanna Briggs Institution (JBI) Cross-Sectional Studies and Cohort Studies checklist. Effect size calculations were made using fixed effects and random effects models.
A total of 22 articles were included in the systematic review, with 14 included in the meta-analysis. The prevalence of streptococcal pharyngitis in these studies ranged from 7.3 to 44.1%. According to the meta-analysis results, a significant association was observed between GAS test positivity and the presence of tonsillar exudate, palatal petechiae, tonsillar hypertrophy, dysphagia, fever, and cervical lymphadenopathy (p < 0.05). No significant relationship was found between GAS test positivity and symptoms such as headache, sore throat, cough, absence of cough, hoarseness, scarlatiniform rash, tonsillar erythema, vomiting, rhinorrhea, and abdominal pain (p > 0.05).
The findings of the meta-analysis suggest that, in addition to the Centor criteria, palatal petechiae, dysphagia, and tonsillar hypertrophy are noteworthy indicators of GAS infection. Contrary to previous studies, our meta-analysis indicates that symptoms such as headache, sore throat, cough, absence of cough, hoarseness, scarlatiniform rash, tonsillar erythema, vomiting, rhinorrhea, and abdominal pain may not be associated with streptococcal infection. Further research is needed to elucidate these findings.
本研究旨在通过系统的荟萃分析得出基于证据的结论,以区分经咽拭子培养或快速检测确诊为A组β溶血性链球菌感染的患者的临床体征和症状,与未经过培养确诊的患者的体征和症状。
该研究方案已发表于国际前瞻性系统评价注册库(PROSPERO,注册号:CRD42023450854)。检索了2013年1月1日至2023年8月15日期间在七个数据库中发表的研究。使用乔安娜·布里格斯循证卫生保健中心(JBI)横断面研究和队列研究清单评估文章的方法学质量。采用固定效应模型和随机效应模型进行效应量计算。
系统评价共纳入22篇文章,荟萃分析纳入14篇。这些研究中链球菌性咽炎的患病率在7.3%至44.1%之间。根据荟萃分析结果,A组链球菌检测阳性与扁桃体渗出物、腭部瘀点、扁桃体肥大、吞咽困难、发热和颈部淋巴结病之间存在显著关联(p<0.05)。A组链球菌检测阳性与头痛、咽痛、咳嗽、无咳嗽、声音嘶哑、猩红热样皮疹、扁桃体红斑、呕吐、流涕和腹痛等症状之间未发现显著关系(p>0.05)。
荟萃分析结果表明,除了森托标准外,腭部瘀点、吞咽困难和扁桃体肥大是A组链球菌感染的重要指标。与以往研究相反,我们的荟萃分析表明,头痛、咽痛、咳嗽、无咳嗽、声音嘶哑、猩红热样皮疹、扁桃体红斑、呕吐、流涕和腹痛等症状可能与链球菌感染无关。需要进一步研究以阐明这些发现。